GOLDMAN SACHS GROUP INC

Holdings History for Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA)

Symbol: AURA on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$762,597	139,926	-55,017	-28%	$5.45	Q4 2025
30 Sep 2025	0%	-0%	$1,204,748	194,943	-17,355	-8.2%	$6.18	Q3 2025
30 Jun 2025	0%	+0%	$1,328,985	212,298	+90,654	+75%	$6.26	Q2 2025
31 Mar 2025	0%	-0%	$712,834	121,644	-32,410		$5.86	Q1 2025
31 Dec 2024	0%	+0%	$1,266,324	154,054	+40,082	+35%	$8.22	Q4 2024
30 Sep 2024	0%	-0%	$1,015,491	113,972	-915,949	-89%	$8.91	Q3 2024
30 Jun 2024	0%	+0%	$7,786,203	1,029,921	+33,278	+3.3%	$7.56	Q2 2024
31 Mar 2024	0%	-0%	$7,823,648	996,643	-40,656	-3.9%	$7.85	Q1 2024
31 Dec 2023	0%	+0%	$9,190,469	1,037,299	+44,097	+4.4%	$8.86	Q4 2023
30 Sep 2023	0%	-0%	$8,909,022	993,202	-33,702	-3.3%	$8.97	Q3 2023
30 Jun 2023	0%	+0%	$12,682,264	1,026,904	+738,406	+256%	$12.35	Q2 2023
31 Mar 2023	0%	+0%	$2,677,261	288,498	+82,918	+40%	$9.28	Q1 2023
31 Dec 2022	0%	+0%	$2,158,590	205,580	+205,580	NEW	$10.50	Q4 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.